Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001008315-06-000008
Filing Date
2006-06-07
Accepted
2006-06-07 12:47:58
Documents
1
Period of Report
2006-06-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 9361
  Complete submission text file 0001008315-06-000008.txt   11140
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address MYRIAD GENETICS INC 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 8015843600
SKOLNICK MARK H (Reporting) CIK: 0001008315 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 06891057